New Hyde Park, NYNCT06747091Now EnrollingIRB Ready

Persistent Atrial Fibrillation Clinical Trial in New Hyde Park, NY

Access cutting-edge persistent atrial fibrillation treatment through this clinical trial at a research site in New Hyde Park. Study-provided care at no cost to qualified participants.

Sponsored by Stavros E Mountantonakis

Quick Self-Assessment

See if you qualify for this New Hyde Park location

Preparing your pre-screening questions…

Expert Care in New Hyde Park

Access persistent atrial fibrillation specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related persistent atrial fibrillation treatment provided free

Apply for This New Hyde Park Location

Check if you qualify for this persistent atrial fibrillation clinical trial in New Hyde Park, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New Hyde Park

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New Hyde Park site if eligible
  4. 4Begin participation

About This Persistent Atrial Fibrillation Study in New Hyde Park

A prospective multi-arm parallel group randomized clinical trial to compare the efficacy of three ablation strategies in patients with persistent atrial fibrillation using using a lattice-tip catheter that can switch between RFA and PFA energy. The incremental benefit of posterior wall isolation (PWI) and mitral isthmus ablation may contribute to greater freedom from atrial fibrillation at twelve months.

Sponsor: Stavros E Mountantonakis

Who Can Participate

Inclusion Criteria

1\. Symptomatic PerAF documented by (1a) a physician's note indicating symptoms consistent with AF sustained longer than 7 days but less than 12 months; AND electrocardiographic evidence 2\. . Suitable candidate for catheter ablation. 3\. . Adults aged 18 - 80 years. 4\. . Willing and able to comply with all baseline and follow-up evaluations for the full length of the study.

Exclusion Criteria

AF secondary to electrolyte imbalance, thyroid disease, acute alcohol intoxication, or other reversible or non-cardiac cause.
Previous left atrial ablation or surgical procedure (including septal closure or left atrial appendage closure).
Valvular cardiac surgical/percutaneous procedure (e.g., ventriculotomy, atriotomy, and valve repair or replacement and presence of a prosthetic valve).
Any carotid stenting or endarterectomy.
Any cardiac procedure (surgical or percutaneous) or percutaneous coronary intervention within the 90 days prior to the initial procedure.
Coronary artery bypass graft (CABG) procedure within the 6 months prior to the initial procedure.
Awaiting cardiac transplantation or other cardiac surgery within the 12 months following the initial ablation procedure.
Documented thromboembolic event (stroke or transient ischemic attack) within 6 months (180 days) prior to the initial ablation procedure.
Documented left atrial thrombus on imaging.
History of blood clotting or bleeding abnormalities.
Any condition contraindicating chronic anticoagulation.
Myocardial infarction (MI) within the 3 months (90 days) prior to the initial procedure.
Body mass index \>40 kg/m2.
Left atrial diameter \>55 mm (anterioposterior).
Diagnosed atrial myxoma.
Uncontrolled heart failure or NYHA Class III or IV heart failure.
Rheumatic heart disease.
Hypertrophic cardiomyopathy.
Unstable angina.
Moderate to severe mitral valve stenosis.
Severe mitral regurgitation (regurgitant volume ≥ 60 mL/beat, regurgitant fraction ≥ 50%, and/or effective regurgitant orifice area ≥ 0.40cm2).
Primary pulmonary hypertension.
Significant restrictive or obstructive pulmonary disease or chronic respiratory condition.
Renal failure requiring dialysis.
History of severe Gastroesophageal Reflux Disease (GERD) requiring surgical and/or mechanical intervention.
Acute illness, active systemic infection, or sepsis.
Contraindication to both computed tomography and magnetic resonance angiography.
Significant congenital anomaly or medical problem that, in the opinion of the investigator, would preclude enrollment in this study or compliance with follow-up requirements or would impact the scientific soundness of the clinical study results.
Current or anticipated participation in any other clinical study of a drug, device, or biologic during the duration of the study not pre-approved by the Sponsor.
Presence of intramural thrombus, tumor, or other abnormality that precludes vascular access, catheter introduction, or manipulation.
Known drug or alcohol dependency.
Life expectancy less than 12 months.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New Hyde Park?

Yes, this clinical trial (NCT06747091) has an active research site in New Hyde Park, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Persistent Atrial Fibrillation Treatment Options in New Hyde Park, NY

If you're searching for persistent atrial fibrillation treatment options in New Hyde Park, NY, this clinical trial (NCT06747091) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New Hyde Park research site is actively enrolling participants for this clinical trial. You'll receive care from experienced persistent atrial fibrillation specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all persistent atrial fibrillation clinical trials near you to find additional studies recruiting in your area.

More Atrial Fibrillation Trials in New Hyde Park, NY

See all atrial fibrillation clinical trials recruiting in New Hyde Park — not just this study.

Browse Atrial Fibrillation Trials in New Hyde Park →

Browse More Trials by Condition

Atrial Fibrillation TrialsPulmonary Embolism TrialsAll Conditions →

Ready to Join in New Hyde Park?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New Hyde Park, NY